Nicola Hulme is a senior research scientist, Bristol Myers Squibb, UK, nicola.hulme@bms.com
Covalidation Strategies to Accelerate Analytical Method Transfer for Breakthrough Therapies
The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.